Cosmos Pharmaceutical - Stock

Cosmos Pharmaceutical ROA 2024

Cosmos Pharmaceutical ROA

0.06

Ticker

3349.T

ISIN

JP3298400007

In 2024, Cosmos Pharmaceutical's return on assets (ROA) was 0.06, a -11.37% increase from the 0.06 ROA in the previous year.

Cosmos Pharmaceutical Aktienanalyse

What does Cosmos Pharmaceutical do?

Cosmos Pharmaceuticals Corp is a Taiwanese company that was founded in 1984. The company specializes in the manufacturing and selling of pharmaceutical and health products, focusing on the needs of patients and healthcare providers. Cosmos Pharmaceuticals Corp has developed a strong business model over the years based on high-quality products, efficient production, and a strong distribution network. The company aims to offer a wide range of products and services to meet customers' needs. It is divided into three main business segments: manufacturing and marketing of drugs, manufacturing and selling of dietary supplements, and sales of medical devices. In the pharmaceutical manufacturing sector, Cosmos Pharmaceuticals Corp offers various drugs, including generics and innovative products that can be used for various conditions such as hypertension, diabetes, and obesity. The company also operates a specialized research center where new active ingredients and therapies are developed. In the dietary supplement sector, Cosmos Pharmaceuticals Corp is known for its products supporting cardiovascular health, immune function, and supplements for the maintenance of hair and skin health. The medical devices division of Cosmos Pharmaceuticals Corp offers a wide range of medical and diagnostic devices, including blood glucose meters, blood pressure monitors, and other devices used by patients and healthcare providers in hospitals and clinics. Furthermore, Cosmos Pharmaceuticals Corp has been committed to quality and customer satisfaction from the beginning. The company has implemented strict quality control standards and a comprehensive quality control system to ensure that all products and services meet the highest standards. The company also has an extensive customer service department that ensures prompt and effective handling of customer inquiries and complaints. Due to its focus on quality products, efficient production, and a strong distribution network, Cosmos Pharmaceuticals Corp has built an excellent reputation over the years. The company has managed to strengthen its presence in Asia and Europe and expand its product range. Cosmos Pharmaceuticals Corp has also established itself as a leading provider of generic and innovative products in Southeast Asia. In summary, Cosmos Pharmaceuticals Corp is a successful and forward-thinking company that strives to meet the needs of its customers and offers a wide range of products and services. With its strong position in the pharmaceutical, dietary supplement, and medical device industries, Cosmos Pharmaceuticals Corp is a company that will continue to grow in the future. Cosmos Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Cosmos Pharmaceutical's Return on Assets (ROA)

Cosmos Pharmaceutical's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Cosmos Pharmaceutical's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Cosmos Pharmaceutical's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Cosmos Pharmaceutical’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Cosmos Pharmaceutical Stock

What is the Return on Assets (ROA) of Cosmos Pharmaceutical this year?

The Return on Assets (ROA) of Cosmos Pharmaceutical is 0.06 undefined this year.

What was the ROA of Cosmos Pharmaceutical compared to the previous year?

The ROA of Cosmos Pharmaceutical has increased by -11.37% compared to the previous year.

What consequences do high ROA have for investors of Cosmos Pharmaceutical?

A high ROA is advantageous for investors of Cosmos Pharmaceutical, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Cosmos Pharmaceutical?

A low ROA can be unfavorable for investors of Cosmos Pharmaceutical as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Cosmos Pharmaceutical affect the company?

An increase in ROA of Cosmos Pharmaceutical can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Cosmos Pharmaceutical impact the company?

A reduction in the ROA of Cosmos Pharmaceutical can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Cosmos Pharmaceutical?

Some factors that can influence the ROA of Cosmos Pharmaceutical include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Cosmos Pharmaceutical important for investors?

The ROA of Cosmos Pharmaceutical is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Cosmos Pharmaceutical take to improve ROA?

To improve ROA, Cosmos Pharmaceutical can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Cosmos Pharmaceutical pay?

Over the past 12 months, Cosmos Pharmaceutical paid a dividend of 117.5 JPY . This corresponds to a dividend yield of about 0.91 %. For the coming 12 months, Cosmos Pharmaceutical is expected to pay a dividend of 129.92 JPY.

What is the dividend yield of Cosmos Pharmaceutical?

The current dividend yield of Cosmos Pharmaceutical is 0.91 %.

When does Cosmos Pharmaceutical pay dividends?

Cosmos Pharmaceutical pays a quarterly dividend. This is distributed in the months of December, June, December, June.

How secure is the dividend of Cosmos Pharmaceutical?

Cosmos Pharmaceutical paid dividends every year for the past 22 years.

What is the dividend of Cosmos Pharmaceutical?

For the upcoming 12 months, dividends amounting to 129.92 JPY are expected. This corresponds to a dividend yield of 1 %.

In which sector is Cosmos Pharmaceutical located?

Cosmos Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Cosmos Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cosmos Pharmaceutical from 8/1/2024 amounting to 60 JPY, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Cosmos Pharmaceutical pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Cosmos Pharmaceutical in the year 2023?

In the year 2023, Cosmos Pharmaceutical distributed 82.5 JPY as dividends.

In which currency does Cosmos Pharmaceutical pay out the dividend?

The dividends of Cosmos Pharmaceutical are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cosmos Pharmaceutical

Our stock analysis for Cosmos Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmos Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.